feed,title,long_url,short_url
Benzinga,Verastem's VS-6766/Defactinib Combo Gets Breakthrough Therapy Tag For Ovarian Cancer; BTIG Upgrades Stock,https://benzinga.com/general/biotech/21/05/21258261/verastems-vs-6766defactinib-combo-gets-breakthrough-therapy-tag-for-ovarian-cancer-btig-upgrades-,https://j.mp/2SqQQkT
